Herbalife/$HLF
1D1W1MYTD1Y5YMAX
Capital at risk
About Herbalife
Herbalife Ltd is a health and wellness company. It provides health and wellness products in 95 markets through a direct-selling business model. Its product categories include Weight Management, Targeted Nutrition, Energy, Sports and Fitness, Outer Nutrition, and Literature, Promotional, and Other. Weight Management generates the majority of revenue, with products such as meal replacements, protein shakes, drink mixes, weight loss enhancers, and healthy snacks. Products are manufactured at facilities in Changsha and Suzhou, China; Lake Forest, California; and Winston-Salem, North Carolina, as well as by third-party providers. Revenues reflect sales to Members across North America, Latin America, EMEA, Asia Pacific, and China.
- Ticker
- $HLF
- Sector
- Consumer Essentials
- Primary listing
- NYSE
- Employees
- 8,500
- Headquarters
- Los Angeles, United States
- Website
- www.herbalife.com
Herbalife Metrics
BasicAdvanced
$1.2B
7.66
$1.54
0.88
-
Price and volume
Market cap
$1.2B
Beta
0.88
52-week high
$20.40
52-week low
$7.56
Average daily volume
1.8M
Financial strength
Current ratio
1.201
Quick ratio
0.503
Long term debt to equity
-4.617
Total debt to equity
-4.72
Interest coverage (TTM)
2.60%
Profitability
EBITDA (TTM)
625.1
Gross margin (TTM)
77.70%
Net profit margin (TTM)
3.16%
Operating margin (TTM)
9.70%
Effective tax rate (TTM)
23.59%
Revenue per employee (TTM)
$610,000
Management effectiveness
Return on assets (TTM)
11.27%
Return on equity (TTM)
-29.06%
Valuation
Price to earnings (TTM)
7.664
Price to revenue (TTM)
0.236
Price to book
-2.61
Price to tangible book (TTM)
-1.33
Price to free cash flow (TTM)
3.806
Free cash flow yield (TTM)
26.27%
Free cash flow per share (TTM)
3.108
Growth
Revenue change (TTM)
5.52%
Earnings per share change (TTM)
-51.27%
3-year revenue growth (CAGR)
1.04%
10-year revenue growth (CAGR)
1.41%
3-year earnings per share growth (CAGR)
-12.12%
10-year earnings per share growth (CAGR)
0.56%
What the Analysts think about Herbalife
Analyst ratings (Buy, Hold, Sell) for Herbalife stock.
Analyst projections of the future price of Herbalife stock.
Bulls say / Bears say
Sustained Sales Growth: Q2 2026 net sales rose 5.4% year-over-year to $1.3 billion, marking the fourth consecutive quarter of growth and reaching the top of the guidance range, driven by a 5.8% constant-currency volume increase (FT.com (markets.ft.markitdigital.com)).
Personalized Nutrition Expansion: Acquisition of UK-based Bioniq assets enhances Herbalife’s personalized nutrition platform, enabling AI-driven supplement formulas to scale rapidly through its global distributor network of over 2 million members (Zawya via TradingView Reuters (tradingview.com)).
Robust Q1 Outperformance and Guidance Upgrade: Preliminary Q1 2026 results outperformed, with net sales growth of 7.5–8.0% and adjusted EBITDA at or above the high end of guidance, underpinning a raise in full-year constant-currency net sales and EBITDA midpoints (FT.com (markets.ft.markitdigital.com)).
Margin and EPS Pressure from FX Headwinds: Q2 2026 adjusted EBITDA margin contracted by 120 bps year-over-year and adjusted EPS missed estimates due to persistent FX headwinds, highlighting profitability vulnerability to currency fluctuations (Bird & Bulllines Reuters (tradingview.com)).
GAAP Net Loss Impacting Earnings: GAAP net loss of $26.3 million in Q2 included a $94.6 million loss on debt extinguishment from April refinancing, which weighed on earnings and reflected significant refinancing costs (Morningstar (morningstar.com)).
Tighter Full-Year Guidance Reflecting FX Risks: Full-year 2026 reported net sales and adjusted EBITDA guidance ranges were narrowed to $670 million–$690 million from $675 million–$705 million due to FX headwinds, underscoring ongoing currency-related risks to financial visibility (SEC 8-K) (sec.gov).
Data summarised monthly by Lightyear AI. Last updated on 31 Aug 2026.
Herbalife Financial Performance
Revenues and expenses
Herbalife Earnings Performance
Company profitability
Upcoming events
No upcoming events
Herbalife News
AllArticlesVideos
Funds containing Herbalife
AllEURUSDGBP
Fund name | Fund size | $HLF weighting |
|---|---|---|
SPDR Russell 2000 US Small Cap€R2US | €4.8B | 0.04% |
iShares MSCI World Small Cap$WSML | $9B | 0.01% |
iShares MSCI World Small Cap€IUSN | €7.8B | 0.01% |
iShares MSCI USA Small Cap ESG Enhanced CTB€SXRG | €2.8B | 0.01% |
iShares MSCI USA Small Cap CTB Enhanced ESG£CUS1 | £2.4B | 0.01% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.